ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.685,64
-0,22%
S&P 500
5.321,41
0,25%
Dow Jones
39.872,99
0,17%
Euro vs US Dollar
1,084
-0,14%
Bitcoin
70.137,11
0,01%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Outlook Therapeutics Inc (OTLKW)

  7. Outlook Therapeutics Inc (OTLKW) News

OTLKW

Outlook Therapeutics (OTLKW)

Outlook Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OTLKW
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202423h00GlobeNewswire Inc.Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate UpdateNASDAQ:OTLKWOutlook Therapeutics Inc
13/05/202414h50GlobeNewswire Inc.Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMDNASDAQ:OTLKWOutlook Therapeutics Inc
09/05/202414h45GlobeNewswire Inc.Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and WebcastNASDAQ:OTLKWOutlook Therapeutics Inc
02/05/202415h05GlobeNewswire Inc.Outlook Therapeutics® to Present at the Retina World Congress 2024NASDAQ:OTLKWOutlook Therapeutics Inc
29/04/202415h00GlobeNewswire Inc.Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation ShowcaseNASDAQ:OTLKWOutlook Therapeutics Inc
15/04/202422h15GlobeNewswire Inc.Outlook Therapeutics® Announces Closing of Private Placement of $5.0 MillionNASDAQ:OTLKWOutlook Therapeutics Inc
22/03/202412h35GlobeNewswire Inc.Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMDNASDAQ:OTLKWOutlook Therapeutics Inc
18/03/202422h10GlobeNewswire Inc.Outlook Therapeutics® Announces Closing of Private Placement of up to $159 MillionNASDAQ:OTLKWOutlook Therapeutics Inc
12/03/202413h05GlobeNewswire Inc.Outlook Therapeutics® Announces Effective Date for 1-for-20 Reverse Stock SplitNASDAQ:OTLKWOutlook Therapeutics Inc
14/02/202414h05GlobeNewswire Inc.Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2024 and Provides Corporate UpdateNASDAQ:OTLKWOutlook Therapeutics Inc
31/01/202414h05GlobeNewswire Inc.Outlook Therapeutics® Doses First Subject in NORSE EIGHTNASDAQ:OTLKWOutlook Therapeutics Inc
23/01/202414h00GlobeNewswire Inc.Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010NASDAQ:OTLKWOutlook Therapeutics Inc
22/12/202314h05GlobeNewswire Inc.Outlook Therapeutics® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EUNASDAQ:OTLKWOutlook Therapeutics Inc
19/12/202314h05GlobeNewswire Inc.Outlook Therapeutics® Submits Special Protocol Assessment (SPA) to FDA for Non-Inferiority Study of ONS-5010NASDAQ:OTLKWOutlook Therapeutics Inc
06/12/202314h05GlobeNewswire Inc.Outlook Therapeutics® Announces Strategic Organizational RealignmentNASDAQ:OTLKWOutlook Therapeutics Inc
27/11/202314h05GlobeNewswire Inc.Outlook Therapeutics® Announces Receipt of Type A Meeting Minutes and Reiterates Regulatory Path Forward for ONS-5010NASDAQ:OTLKWOutlook Therapeutics Inc
14/11/202314h05GlobeNewswire Inc.Outlook Therapeutics® Adds Global Commercial Expertise with Appointment of Jedd Comiskey as Senior VP - Head of EuropeNASDAQ:OTLKWOutlook Therapeutics Inc
02/11/202313h05GlobeNewswire Inc.Outlook Therapeutics® Provides Update on Type A Meetings with FDANASDAQ:OTLKWOutlook Therapeutics Inc
01/11/202313h05GlobeNewswire Inc.Outlook Therapeutics® to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology (INI) ConferenceNASDAQ:OTLKWOutlook Therapeutics Inc
29/09/202314h05GlobeNewswire Inc.Outlook Therapeutics® Requests Type A Meeting With FDANASDAQ:OTLKWOutlook Therapeutics Inc
21/09/202314h05GlobeNewswire Inc.Outlook Therapeutics® to Present at the 2023 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:OTLKWOutlook Therapeutics Inc
05/09/202314h05GlobeNewswire Inc.Outlook Therapeutics® to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:OTLKWOutlook Therapeutics Inc
30/08/202312h00GlobeNewswire Inc.Outlook Therapeutics® Provides Regulatory Update on FDA Review of ONS-5010 / LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMDNASDAQ:OTLKWOutlook Therapeutics Inc
14/08/202314h05GlobeNewswire Inc.Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2023 and Reiterates Key Anticipated Near-Term MilestonesNASDAQ:OTLKWOutlook Therapeutics Inc
01/08/202314h45GlobeNewswire Inc.Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2023NASDAQ:OTLKWOutlook Therapeutics Inc
16/05/202313h10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OTLKWOutlook Therapeutics Inc
16/05/202312h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTLKWOutlook Therapeutics Inc
15/05/202322h51Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTLKWOutlook Therapeutics Inc
15/05/202314h05GlobeNewswire Inc.Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2023 and Provides Corporate UpdateNASDAQ:OTLKWOutlook Therapeutics Inc
27/04/202314h05GlobeNewswire Inc.Outlook Therapeutics® to Present at the H.C. Wainwright BioConnect Investor ConferenceNASDAQ:OTLKWOutlook Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:OTLKW

Kürzlich von Ihnen besucht

COIN
MODXGBP
NASDAQ
CSAXX
Cash Account Trust
DBI
I1NZ
Xtr MSCI Emerging Market...
USOTC
SNGWF
SG Issuer (GM)
NYSE
NHA
Nuveen Municipal 2021 Ta...
COIN
GUSEUR
BOV
BBASV455
BBASV455 Ex:22,22
COIN
EZWETH
EZOOW
BIT
UIE478
Unicredit Bank
LSE
0QFG
EU
L512S
L512S
AMEX
FCLD
Fidelity Cloud Computing...
TG
2H51
Ocugen
EU
SNBT
SNCF International bond ...
USOTC
TSHMY
Shibaura Machine (PK)
USOTC
VIMGF
Vimian Group AB (PK)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten